The Human Touch: Using a Webcam to Autonomously Monitor Compliance During Visual Field Assessments.

OpenFace action units adherence affective computing compliance computer vision deep learning eye gaze facial expression glaucoma head pose machine learning measurement error perimetry psychophysics reliability vigilance visual fields

Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
07 2020
Historique:
received: 05 11 2019
accepted: 16 03 2020
entrez: 29 8 2020
pubmed: 29 8 2020
medline: 29 8 2020
Statut: epublish

Résumé

To explore the feasibility of using various easy-to-obtain biomarkers to monitor non-compliance (measurement error) during visual field assessments. Forty-two healthy adults (42 eyes) and seven glaucoma patients (14 eyes) underwent two same-day visual field assessments. An ordinary webcam was used to compute seven potential biomarkers of task compliance, based primarily on eye gaze, head pose, and facial expression. We quantified the association between each biomarker and measurement error, as defined by (1) test-retest differences in overall test scores (mean sensitivity), and (2) failures to respond to visible stimuli on individual trials (stimuli -3 dB or more brighter than threshold). In healthy eyes, three of the seven biomarkers were significantly associated with overall (test-retest) measurement error ( Inexpensive, autonomous measures of task compliance are associated with measurement error in visual field assessments, in terms of both the overall reliability of a test and failures to respond on particular trials ("lapses"). This could be helpful for identifying low-quality assessments and for improving assessment techniques (e.g., by discounting suspect responses or by automatically triggering comfort breaks or encouragement). This study explores a potential way of improving the reliability of visual field assessments, a crucial but notoriously unreliable clinical measure.

Identifiants

pubmed: 32855877
doi: 10.1167/tvst.9.8.31
pii: TVST-19-2093
pmc: PMC7422775
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

31

Informations de copyright

Copyright 2020 The Authors.

Déclaration de conflit d'intérêts

Disclosure: P.R. Jones, None; G. Demaria, None; I. Tigchelaar, None; D.S. Asfaw, None; D.F. Edgar, None; P. Campbell, None; T. Callaghan, None; D.P. Crabb, None

Références

Atten Percept Psychophys. 2019 Jul;81(5):1189-1196
pubmed: 31089976
Invest Ophthalmol Vis Sci. 1997 Feb;38(2):426-35
pubmed: 9040476
Ophthalmology. 2017 Dec;124(12):1735-1742
pubmed: 28764889
Behav Res Methods. 2019 Feb;51(1):28-39
pubmed: 29770907
PLoS One. 2015 Jun 18;10(6):e0130293
pubmed: 26086771
Transl Vis Sci Technol. 2019 Feb 5;8(1):17
pubmed: 30740267
IEEE Trans Cybern. 2014 Mar;44(3):315-28
pubmed: 23757552
J Neurosci. 2014 Jan 29;34(5):1724-30
pubmed: 24478354
Optom Vis Sci. 2000 Dec;77(12):653-62
pubmed: 11147735
Nat Neurosci. 2015 Mar;18(3):470-5
pubmed: 25664913
Am J Ophthalmol. 1989 Aug 15;108(2):130-5
pubmed: 2757094
Ophthalmol Glaucoma. 2019 Mar - Apr;2(2):111-119
pubmed: 32672604
Invest Ophthalmol Vis Sci. 2015 Dec 1;56(13):7801-7805
pubmed: 26650899
Invest Ophthalmol Vis Sci. 2011 Jun 28;52(7):4546-50
pubmed: 21447676
Nat Biomed Eng. 2019 Nov;3(11):860-869
pubmed: 31636413
Invest Ophthalmol Vis Sci. 1993 Dec;34(13):3534-40
pubmed: 8258511
Am J Ophthalmol. 2019 Feb;198:154-165
pubmed: 30336129
Invest Ophthalmol Vis Sci. 2012 Oct 09;53(11):7010-7
pubmed: 22952121
Transl Vis Sci Technol. 2018 Mar 23;7(2):8
pubmed: 29600116
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2201-4
pubmed: 10892863
Nat Neurosci. 2016 Jan;19(1):165-71
pubmed: 26595653
Invest Ophthalmol Vis Sci. 2015 Sep;56(10):6077-83
pubmed: 26393667
Ophthalmology. 1997 Jul;104(7):1126-30
pubmed: 9224465
J Cogn Neurosci. 2015 Aug;27(8):1601-16
pubmed: 25811710
J Am Optom Assoc. 1995 Nov;66(11):706-11
pubmed: 8576536
BMJ Open. 2014 Jan 10;4(1):e003996
pubmed: 24413347
Br J Ophthalmol. 2008 Apr;92(4):569-73
pubmed: 18211935
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2654-9
pubmed: 12147599
Cereb Cortex. 2013 Nov;23(11):2712-23
pubmed: 22941724
PLoS One. 2016 Mar 03;11(3):e0150922
pubmed: 26937972
Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3540-3
pubmed: 20207962
J Vis. 2017 Mar 1;17(3):10
pubmed: 28355623
Transl Vis Sci Technol. 2019 Jun 28;8(3):59
pubmed: 31293814
Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5631-5636
pubmed: 27784065
Cogn Affect Behav Neurosci. 2016 Aug;16(4):601-15
pubmed: 27038165
Vision Res. 2002 Mar;42(6):781-7
pubmed: 11888543
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3189-3198
pubmed: 29971443
Educ Psychol. 2017;52(2):104-123
pubmed: 29038607
PLoS One. 2016 Oct 21;11(10):e0165274
pubmed: 27768778
Am J Ophthalmol. 1994 Jun 15;117(6):756-61
pubmed: 8198159
Psychophysiology. 1973 May;10(3):270-94
pubmed: 4702521
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):E1454-62
pubmed: 24706770
Lancet. 2015 Apr 4;385(9975):1295-304
pubmed: 25533656
IEEE Trans Biomed Eng. 2007 May;54(5):832-9
pubmed: 17518279
Optom Vis Sci. 2005 Nov;82(11):981-7
pubmed: 16317375
Invest Ophthalmol Vis Sci. 1995 Mar;36(3):671-85
pubmed: 7890497
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4787-95
pubmed: 14578400
Am J Ophthalmol. 2006 Jan;141(1):24-30
pubmed: 16386972
IEEE Trans Biomed Eng. 1997 Jan;44(1):60-9
pubmed: 9214784
JAMA Ophthalmol. 2015 Jan;133(1):40-4
pubmed: 25256758

Auteurs

Pete R Jones (PR)

Division of Optometry and Visual Sciences, School of Health Sciences, City, University of London, London, UK.

Giorgia Demaria (G)

Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Graduate School of Medical Sciences (Research School of Behavioral and Cognitive Neurosciences), University of Groningen, Groningen, The Netherlands.

Iris Tigchelaar (I)

Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Ocusweep, Turku, Finland.
Doctoral Program in Clinical Research, University of Turku and Turku University Hospital, Turku, Finland.

Daniel S Asfaw (DS)

Division of Optometry and Visual Sciences, School of Health Sciences, City, University of London, London, UK.

David F Edgar (DF)

Division of Optometry and Visual Sciences, School of Health Sciences, City, University of London, London, UK.

Peter Campbell (P)

Division of Optometry and Visual Sciences, School of Health Sciences, City, University of London, London, UK.
Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Tamsin Callaghan (T)

Division of Optometry and Visual Sciences, School of Health Sciences, City, University of London, London, UK.

David P Crabb (DP)

Division of Optometry and Visual Sciences, School of Health Sciences, City, University of London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH